Hepatitis B surface antigen (HBsAg) infection in a hemodialysis unit. II. Factors affecting host immune response to HBsAg.
Serum from 86 hemodialysis patients, 105 healthy hospital staff "at risk" and 160 regular hospital staff was screened for hepatitis B surface antigen (HBsAg) and antibody (anti-HBs). The combined prevalence of HBsAg and anti-HBs was higher in the staff of the artificial kidney unit (57.7%) than in the hemodialysis patients (33.7%). The healthy subjects with HBsAg infection responded significantly more often by producing anti-HBs compared with the hemodialysis patients. Twelve of 29 (41.4%) hemodialysis patients with HBsAg infection produced anti-HBs, while 17 (58.6%) remained positive for HBsAg. This differential response could not be attributed to age, sex, time spent undergoing hemodialysis, delayed cutaneous reactivity or response to phytohemagglutinin (PHA) or pokeweed mitogen (PWM). However, a much larger proportion of patients with HBsAg than with anti-HBs had previously received blood transfusions (88.2% v. 33.3%). Our results indicate that development of the chronic HBsAg carrier state or production of anti-HBs in uremic patients may be influenced by the route of immunization or the dose of antigen, or both. Although uremic patients maintain normal in vitro response to PHA and PWM, they may have depressed immunity in vivo because of a decreased total number of T-lymphocytes.
D000328:Adult; D000368:Aged; D000914:Antibodies, Viral / Q000032:analysis; D000917:Antibody Formation; D001803:Blood Transfusion; D002353:Carrier State / Q000453:epidemiology; D002462:Cell Membrane / Q000276:immunology; D005260:Female; D006509:Hepatitis B / Q000453:epidemiology* / Q000276:immunology; D006511:Hepatitis B Antigens / Q000032:analysis*; D006801:Humans; D007111:Immunity, Cellular; D016030:Kidney Transplantation; D037102:Lectins / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D008934:Mitogens / Q000494:pharmacology; D010564:Personnel, Hospital; D006435:Renal Dialysis; D013601:T-Lymphocytes / Q000276:immunology; D014184:Transplantation, Homologous
D000914:Antibodies, Viral; D006511:Hepatitis B Antigens; D037102:Lectins; D008934:Mitogens